跳到主要导航 跳到搜索 跳到主要内容

Studies on pharmacokinetics of recombinant human basic fibroblast growth factor in rabbits by 125I radioiodination and enzyme linked immunosorbent assay

  • China Pharmaceutical University
  • Nanjing Tech University

科研成果: 期刊稿件 › 文章 › 同行评审

摘要

Aim: To compare the recombinant human basic fibroblast growth factor (rhbFGF) pharmacokinetic results from 125I radioiodination method and enzyme linked immunosorbent assay (ELISA). Method: Establishing 125I radioiodination method and ELISA to examine the fate of rhbFGF in rabbits. Result: Pharmacokinetic parameters were calculated by statistical analysis after iv administration of 4, 2 and 1 μg/kg of 125I-rhbFGF or rhbFGF in rabbits, with 98.84, 75.15, 71.57 min for t1/2 and about 5 min for Cltot in radioiodination method, and 17.18, 16.24, 23.92 min for t1/2 and about 10 min for Cltot in ELISA. The AUCs were linearly correlated to doses in both cases (rradioiodination = 0.9999; rELISA = 0.9982. The results from two methods have a correspondence, and significant differences also exist. Conclusion: Labelled rhbFGF presents the different fate in rabbits compared with unlabelled rhbFGF.

源语言英语
页(从-至)536-539
页数4
期刊Journal of China Pharmaceutical University
卷35
期6
出版状态已出版 - 12月 2004
已对外发布是

学术指纹

探究 'Studies on pharmacokinetics of recombinant human basic fibroblast growth factor in rabbits by 125I radioiodination and enzyme linked immunosorbent assay' 的科研主题。它们共同构成独一无二的学术指纹。

引用此